Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Galena raises $35 million in follow-on

Galena Biopharma Inc. (NASDAQ:GALE) raised $35 million through the sale of 17.5 million units at $2 in a

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE